PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsheart diseases
MeSH D006331 - heart diseases
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D002318:Cardiovascular diseases
$
Success rate
D006331: 
Heart diseases
0 Companies
0 Drugs
Success rate
D000075224:Cardiac conduction system disease
0 Companies
0 Drugs
Success rate
D000080942:Post-cardiac arrest syndrome
0 Companies
0 Drugs
Success rate
D001145:Cardiac arrhythmias
D002275:Carcinoid heart disease
0 Companies
0 Drugs
Success rate
D002303:Low cardiac output
$
Success rate
D002305:Cardiac tamponade
0 Companies
0 Drugs
Success rate
D004696:Endocarditis
$
Success rate
D006322:Heart aneurysm
0 Companies
0 Drugs
Success rate
D006323:Heart arrest
D006330:Congenital heart defects
0 Companies
0 Drugs
Success rate
D006332:Cardiomegaly
0 Companies
0 Drugs
Success rate
D006333:Heart failure
D006338:Heart neoplasms
0 Companies
0 Drugs
Success rate
D006341:Heart rupture
0 Companies
0 Drugs
Success rate
D006349:Heart valve diseases
0 Companies
0 Drugs
Success rate
D009202:Cardiomyopathies
0 Companies
0 Drugs
Success rate
D010490:Pericardial effusion
0 Companies
0 Drugs
Success rate
D010493:Pericarditis
$
Success rate
D011026:Pneumopericardium
0 Companies
0 Drugs
Success rate
D011185:Postpericardiotomy syndrome
0 Companies
0 Drugs
Success rate
D011660:Pulmonary heart disease
0 Companies
0 Drugs
Success rate
D012214:Rheumatic heart disease
0 Companies
0 Drugs
Success rate
D014694:Ventricular outflow obstruction
0 Companies
0 Drugs
Success rate
D016534:High cardiac output
0 Companies
0 Drugs
Success rate
D017202:Myocardial ischemia
0 Companies
0 Drugs
Success rate
D017682:Myocardial stunning
0 Companies
0 Drugs
Success rate
D018754:Ventricular dysfunction
$
Success rate
D066126:Cardiotoxicity
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
71%
12/17
Phase 2
60%
45/75
Phase 3
9%
11/118
Approved: 0Overall Success rate: 4%
All Clinical Trials
No data
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use